» Articles » PMID: 25350848

From a 2DE-gel Spot to Protein Function: Lesson Learned from HS1 in Chronic Lymphocytic Leukemia

Overview
Journal J Vis Exp
Date 2014 Oct 29
PMID 25350848
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The identification of molecules involved in tumor initiation and progression is fundamental for understanding disease's biology and, as a consequence, for the clinical management of patients. In the present work we will describe an optimized proteomic approach for the identification of molecules involved in the progression of Chronic Lymphocytic Leukemia (CLL). In detail, leukemic cell lysates are resolved by 2-dimensional Electrophoresis (2DE) and visualized as "spots" on the 2DE gels. Comparative analysis of proteomic maps allows the identification of differentially expressed proteins (in terms of abundance and post-translational modifications) that are picked, isolated and identified by Mass Spectrometry (MS). The biological function of the identified candidates can be tested by different assays (i.e. migration, adhesion and F-actin polymerization), that we have optimized for primary leukemic cells.

Citing Articles

3D-STED Super-Resolution Microscopy Reveals Distinct Nanoscale Organization of the Hematopoietic Cell-Specific Lyn Substrate-1 (HS1) in Normal and Leukemic B Cells.

Sampietro M, Zamai M, Diaz Torres A, Labrador Cantarero V, Barbaglio F, Scarfo L Front Cell Dev Biol. 2021; 9:655773.

PMID: 34277604 PMC: 8278786. DOI: 10.3389/fcell.2021.655773.


Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line.

Agathangelidis A, Scarfo L, Barbaglio F, Apollonio B, Bertilaccio M, Ranghetti P PLoS One. 2015; 10(6):e0130195.

PMID: 26110819 PMC: 4481539. DOI: 10.1371/journal.pone.0130195.

References
1.
Caligaris-Cappio F, Bertilaccio M, Scielzo C . How the microenvironment wires the natural history of chronic lymphocytic leukemia. Semin Cancer Biol. 2013; 24:43-8. DOI: 10.1016/j.semcancer.2013.06.010. View

2.
Ummanni R, Mundt F, Pospisil H, Venz S, Scharf C, Barett C . Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platform. PLoS One. 2011; 6(2):e16833. PMC: 3037937. DOI: 10.1371/journal.pone.0016833. View

3.
Muzio M, Scielzo C, Frenquelli M, Bachi A, De Palma M, Alessio M . HS1 complexes with cytoskeleton adapters in normal and malignant chronic lymphocytic leukemia B cells. Leukemia. 2007; 21(9):2067-70. DOI: 10.1038/sj.leu.2404744. View

4.
Scielzo C, Ghia P, Conti A, Bachi A, Guida G, Geuna M . HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses. J Clin Invest. 2005; 115(6):1644-50. PMC: 1136999. DOI: 10.1172/JCI24276. View

5.
Dhamoon A, Kohn E, Azad N . The ongoing evolution of proteomics in malignancy. Drug Discov Today. 2007; 12(17-18):700-8. DOI: 10.1016/j.drudis.2007.07.015. View